Vaxart, Inc. (VXRT)
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. The company is headquartered in South San Francisco, California.
$206.08M
Mr. Cezar Andrei Floroiu M.B.A.
110.00
South San Francisco, CA
Mar 17, 1980
-2.01
$-0.45
3.12
5.13
-4,910.80%
-1.06
0.00
1.26
56.74
4.89
-82.28%
-99.00%
Similar stocks (5)
Novavax, Inc.
NVAX
Ocugen, Inc.
OCGN
Inovio Pharmaceuticals, Inc.
INO
Co-Diagnostics, Inc.
CODX
iBio, Inc.
IBIO
ETF Exposure (13)
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.563%
ETFMG Treatments, Testing and Advancements ETF
GERM
0.24%
Fidelity Nasdaq Composite Index ETF
ONEQ
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (5)
Novavax, Inc.
NVAX
Ocugen, Inc.
OCGN
Inovio Pharmaceuticals, Inc.
INO
Co-Diagnostics, Inc.
CODX
iBio, Inc.
IBIO
ETF Exposure (13)
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.563%
ETFMG Treatments, Testing and Advancements ETF
GERM
0.24%
Fidelity Nasdaq Composite Index ETF
ONEQ
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%